Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.59 EUR
−12.47 M EUR
24.33 M EUR
13.48 M
About BioHarvest Sciences, Inc.
Sector
Industry
CEO
Ilan Sobel
Website
Headquarters
Vancouver
Founded
2013
ISIN
CA09076J2074
FIGI
BBG0152NTDK2
BioHarvest Sciences, Inc. develops bio-cell growth platform technology. The firm engages in botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions. It offers nutraceutical health and wellness products, which includes dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients. The company was founded on April 19, 2013 and is headquartered in Vancouver, Canada.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 8MV0 is 9.35 EUR — it has decreased by −6.50% in the past 24 hours. Watch BioHarvest Sciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange BioHarvest Sciences, Inc. stocks are traded under the ticker 8MV0.
8MV0 stock has risen by 28.08% compared to the previous week, the month change is a 20.65% rise, over the last year BioHarvest Sciences, Inc. has showed a 91.21% increase.
We've gathered analysts' opinions on BioHarvest Sciences, Inc. future price: according to them, 8MV0 price has a max estimate of 12.86 EUR and a min estimate of 12.01 EUR. Watch 8MV0 chart and read a more detailed BioHarvest Sciences, Inc. stock forecast: see what analysts think of BioHarvest Sciences, Inc. and suggest that you do with its stocks.
8MV0 reached its all-time high on Aug 27, 2025 with the price of 8.30 EUR, and its all-time low was 4.25 EUR and was reached on Oct 29, 2024. View more price dynamics on 8MV0 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
8MV0 stock is 8.11% volatile and has beta coefficient of 0.99. Track BioHarvest Sciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is BioHarvest Sciences, Inc. there?
Today BioHarvest Sciences, Inc. has the market capitalization of 163.47 M, it has increased by 21.92% over the last week.
Yes, you can track BioHarvest Sciences, Inc. financials in yearly and quarterly reports right on TradingView.
BioHarvest Sciences, Inc. is going to release the next earnings report on Dec 1, 2025. Keep track of upcoming events with our Earnings Calendar.
8MV0 earnings for the last quarter are −0.20 EUR per share, whereas the estimation was −0.09 EUR resulting in a −118.18% surprise. The estimated earnings for the next quarter are −0.10 EUR per share. See more details about BioHarvest Sciences, Inc. earnings.
BioHarvest Sciences, Inc. revenue for the last quarter amounts to 7.23 M EUR, despite the estimated figure of 7.24 M EUR. In the next quarter, revenue is expected to reach 7.81 M EUR.
8MV0 net income for the last quarter is −3.46 M EUR, while the quarter before that showed −2.16 M EUR of net income which accounts for −60.27% change. Track more BioHarvest Sciences, Inc. financial stats to get the full picture.
No, 8MV0 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 27, 2025, the company has 87 employees. See our rating of the largest employees — is BioHarvest Sciences, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BioHarvest Sciences, Inc. EBITDA is −4.94 M EUR, and current EBITDA margin is −22.78%. See more stats in BioHarvest Sciences, Inc. financial statements.
Like other stocks, 8MV0 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BioHarvest Sciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BioHarvest Sciences, Inc. technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BioHarvest Sciences, Inc. stock shows the strong buy signal. See more of BioHarvest Sciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.